Table 3.
Generalized linear mixed analysis for the comparison of the progression over time of clinical variables between de novo Parkinson’s patients with stable weight, weight loss, or weight gain.
Outcome | Baseline (n = 406) |
Year 1 (n = 363) |
Year 2 (n = 363) |
Year 3 (n = 359) |
Year 4 (n = 341) |
Year 5 (n = 314) |
Group × Time effect | |
---|---|---|---|---|---|---|---|---|
Est (SE) | p | |||||||
MDS- UPDRS I | ||||||||
Stable weight | 5.4 ± 4.0 | 6.7 ± 4.7 | 7.3 ± 4.8 | 7.8 ± 5.3 | 8.7 ± 5.7 | 8.9 ± 5.8 | ||
Weight loss | 5.7 ± 3.9 | 7.3 ± 4.7 | 7.8 ± 5.5 | 9.1 ± 5.5 | 9.9 ± 6.7 | 10.0 ± 7.1 | 0.22 (0.09) | 0.013 |
Weight gain | 5.9 ± 4.4 | 6.3 ± 4.3 | 8.0 ± 5.2 | 8.2 ± 5.7 | 8.9 ± 4.6 | 9.7 ± 5.7 | 0.25 (0.11) | 0.026 |
MDS- UPDRS II | ||||||||
Stable weight | 5.5 ± 4.1 | 7.0 ± 4.9 | 7.5 ± 5.2 | 8.1 ± 5.4 | 9.4 ± 6.6 | 9.4 ± 5.8 | ||
Weight loss | 6.2 ± 4.3 | 8.4 ± 5.2 | 8.9 ± 5.5 | 10.3 ± 6.2 | 10.8 ± 7.2 | 11.5 ± 7.7 | 0.32 (0.09) | <0.001* |
Weight gain | 6.3 ± 4.1 | 7.2 ± 4.4 | 7.4 ± 4.5 | 8.0 ± 4.6 | 9.4 ± 5.8 | 10.0 ± 5.7 | −0.01 (0.1) | 0.945 |
MDS- UPDRS III | ||||||||
Stable weight | 19.4 ± 8.2 | 22.7 ± 9.4 | 25.2 ± 11.5 | 27.6 ± 12.3 | 26.9 ± 11.4 | 30.6 ± 12.4 | ||
Weight loss | 22.0 ± 9.2 | 27.4 ± 10.7 | 30.1 ± 10.5 | 33.1 ± 11.4 | 34.3 ± 12.4 | 33.7 ± 12.9 | 0.45 (0.2) | 0.854 |
Weight gain | 22.7 ± 9.5 | 23.7 ± 12.0 | 27.3 ± 12.8 | 25.7 ± 11.2 | 29.5 ± 14.0 | 29.1 ± 11.8 | −0.81 (0.3) | <0.001* |
MDS- UPDRS IV | ||||||||
Stable weight | NA | 0.4 ± 1.3 | 0.7 ± 1.7 | 1.0 ± 1.8 | 1.6 ± 2.5 | 2.1 ± 2.8 | ||
Weight loss | NA | 0.4 ± 1.3 | 0.9 ± 2.1 | 1.0 ± 2.2 | 1.6 ± 2.9 | 2.0 ± 3.2 | −0.003 (0.02) | 0.962 |
Weight gain | NA | 0.6 ± 1.6 | 0.3 ± 0.9 | 0.5 ± 1.3 | 1.3 ± 2.4 | 2.4 ± 2.8 | 0.02 (0.09) | 0.696 |
MDS-UPDRS | ||||||||
Stable weight | 30.3 ± 12.5 | 36.1 ± 14.5 | 39.4 ± 17.4 | 42.6 ± 18.1 | 46.3 ± 17.9 | 48.0 ± 18.5 | ||
Weight loss | 33.9 ± 13.1 | 43.6 ± 16.8 | 46.9 ± 16.6 | 52.7 ± 18.8 | 53.8 ± 22.1 | 53.8 ± 21.2 | 1.07 (0.32) | 0.001* |
Weight gain | 34.3 ± 14.5 | 37.4 ± 16.4 | 42.8 ± 16.6 | 41.5 ± 16.6 | 46.8 ± 20.1 | 50.0 ± 18.9 | −0.40 (0.41) | 0.340 |
ADL | ||||||||
Stable weight | 94.0 ± 5.4 | 91.0 ± 7.0 | 89.2 ± 8.3 | 88.4 ± 7.8 | 86.6 ± 10.3 | 86.0 ± 10.4 | ||
Weight loss | 91.9 ± 6.2 | 89.7 ± 6.3 | 87.4 ± 8.2 | 86.0 ± 8.5 | 83.0 ± 10.3 | 80.5 ± 16.4 | 0.07 (0.18) | <0.001* |
Weight gain | 93.4 ± 6.2 | 91.2 ± 6.3 | 90.6 ± 6.4 | 89.5 ± 7.5 | 88.2 ± 3.7 | 86.9 ± 8.0 | 0.27 (0.23) | 0.237 |
MoCA | ||||||||
Stable weight | 26.9 ± 2.4 | 26.4 ± 2.7 | 26.3 ± 2.9 | 26.6 ± 2.8 | 26.8 ± 3.1 | 27.0 ± 2.9 | ||
Weight loss | 27.3 ± 2.2 | 26.3 ± 3.0 | 26.2 ± 3.6 | 26.1 ± 3.3 | 25.7 ± 4.1 | 25.4 ± 4.6 | 0.35 (0.05) | <0.001* |
Weight gain | 27.2 ± 2.2 | 26.1 ± 2.7 | 26.2 ± 3.2 | 26.5 ± 3.1 | 26.5 ± 3.7 | 27.2 ± 2.7 | 0.05 (0.06) | 0.448 |
GDS | ||||||||
Stable weight | 2.1 ± 2.2 | 2.3 ± 2.8 | 2.3 ± 2.6 | 2.3 ± 2.6 | 2.5 ± 2.6 | 2.5 ± 2.6 | ||
Weight loss | 2.3 ± 2.3 | 2.7 ± 3.1 | 2.7 ± 2.9 | 3.1 ± 3.1 | 2.8 ± 3.1 | 3.3 ± 3.2 | 0.10 (0.05) | 0.061 |
Weight gain | 2.8 ± 3.1 | 2.7 ± 2.7 | 3.4 ± 3.4 | 2.7 ± 2.7 | 2.6 ± 2.8 | 2.7 ± 2.6 | −0.10 (0.06) | 0.116 |
STAI | ||||||||
Stable weight | 63.9 ± 18.0 | 64.1 ± 18.5 | 62.9 ± 17.4 | 63.6 ± 17.9 | 64.2 ± 18.1 | 63.7 ± 18.1 | ||
Weight loss | 64.7 ± 17.3 | 65.7 ± 18.3 | 67.3 ± 20.1 | 66.7 ± 20.7 | 65.7 ± 19.6 | 67.8 ± 22.7 | 0.42 (0.30) | 0.167 |
Weight gain | 69.7 ± 20.3 | 68.0 ± 19.5 | 68.1 ± 19.0 | 65.3 ± 18.5 | 65.6 ± 19.1 | 63.4 ± 16.5 | −1.10 (0.39) | 0.004* |
SCOPA | ||||||||
Stable weight | 8.9 ± 5.7 | 10.5 ± 6.2 | 10.6 ± 6.3 | 11.3 ± 6.6 | 11.8 ± 7.1 | 12.7 ± 8.1 | ||
Weight loss | 10.2 ± 6.6 | 12.3 ± 6.8 | 12.7 ± 7.0 | 14.2 ± 7.8 | 14.2 ± 8.2 | 15.2 ± 9.0 | 0.20 (0.10) | 0.061 |
Weight gain | 8.8 ± 5.4 | 9.83 ± 6.0 | 11.2 ± 5.3 | 11.8 ± 6.2 | 12.9 ± 6.0 | 13.6 ± 5.5 | 0.18 (0.13) | 0.168 |
ESS | ||||||||
Stable weight | 5.5 ± 3.1 | 6.1 ± 4.1 | 6.7 ± 4.4 | 7.2 ± 4.4 | 7.4 ± 4.5 | 7.6 ± 4.5 | ||
Weight loss | 6.4 ± 3.8 | 6.5 ± 4.0 | 6.6 ± 4.0 | 7.6 ± 4.7 | 7.6 ± 4.8 | 8.0 ± 4.7 | −0.06 (0.08) | 0.433 |
Weight gain | 4.8 ± 2.8 | 5.6 ± 3.5 | 6.8 ± 4.0 | 7.0 ± 4.0 | 7.3 ± 4.8 | 7.7 ± 5.2 | 0.18 (0.09) | 0.060 |
NA not applicable, MDS-UPDRS Movement Disorders Society Unified Parkinson Disease Rating Scale, MoCA Montreal Cognitive Assessment. SCOPA-AUT SCOPA-autonomic, UPSIT University of Pennsylvania Smell Identification Test, GDS Geriatric Depression Scale, STAI State-Trait Anxiety Inventory, ESS Epworth Sleepiness Scale.
*Significant p-values after Bonferroni correction for multiple testing.